Key host responses to the stress induced by environmental exposure to cigarette
smoke (CS) are responsible for initiating pathogenic effects that may culminate in
emphysema development. CS increases lung
ceramides,
sphingolipids involved in oxidative stress, structural alveolar cell apoptosis, and inhibition of apoptotic cell clearance by alveolar macrophages, leading to the development of
emphysema-like pathology. RTP801, a
hypoxia and oxidative stress sensor, is also increased by CS, and has been recently implicated in both apoptosis and
inflammation. We investigated whether inductions of
ceramide and RTP801 are mechanistically linked, and evaluated their relative importance in lung cell apoptosis and airspace enlargement in vivo. As reported, direct lung instillation of either RTP801 expression plasmid or
ceramides in mice triggered alveolar cell apoptosis and oxidative stress. RTP801 overexpression up-regulated lung
ceramide levels 2.6-fold. In turn, instillation of lung
ceramides doubled the lung content of RTP801. Cell sorting after lung tissue dissociation into single-cell
suspension showed that
ceramide triggers both endothelial and epithelial cell apoptosis in vivo. Interestingly, mice lacking rtp801 were protected against
ceramide-induced apoptosis of epithelial type II cells, but not type I or endothelial cells. Furthermore, rtp801-null mice were protected from
ceramide-induced alveolar enlargement, and exhibited improved static lung compliance compared with wild-type mice. In conclusion,
ceramide and RTP801 participate in alveolar cell apoptosis through a process of mutual up-regulation, which may result in self-amplification loops, leading to alveolar damage.